038290 — Macrogen Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Macrogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	87,875	2,312	-22,005	-16,751	-7,784
Depreciation
Amortisation
Non-Cash Items	-87,421	9,265	24,378	17,727	4,220
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	6,546	-1,065	-2,580	-7,408	-111
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	20,553	21,183	10,767	4,765	7,124
Capital Expenditures	-13,928	-9,234	-19,783	-24,347	-35,487
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	9,654	4,794	5,135	9,019	11,367
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-4,274	-4,441	-14,648	-15,328	-24,120
Financing Cash Flow Items	-257	598	359	88.1	135
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-4,586	-6,532	3,139	-5,008	26,896
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	11,983	10,466	-893	-14,634	9,833